Literature DB >> 15141345

Vitamin D receptor gene polymorphism in hypercalciuric children.

Oğuz Söylemezoğlu1, Ozan Ozkaya, Sevim Gönen, Müge Misirlioğlu, Süleyman Kalman, Necla Buyan.   

Abstract

Idiopathic hypercalciuria is a complex disease resulting from an interaction between environmental and genetic factors. Recently, the relationship between vitamin D receptor ( VDR) alleles and calcium homeostasis has been investigated. This study was conducted to explore the association of VDR gene polymorphism with the risk of absorptive hypercalciuria (AH). We investigated the VDR gene polymorphisms, ApaI, BsmI, and TaqI, in relation to intact parathormone (PTH), osteocalcin, and 25-hydroxyvitamin D in 80 children (42 males, 38 girls) with AH and in 86 healthy children without hypercalciuria. A significant difference in the ApaI genotype was observed between the AH group and the control group ( chi(2)=7.21, P=0.027). The AA genotype was associated with a 3.5-fold increased risk for idiopathic hypercalciuria compared with the Aa/aa genotype (odds ratio 3.5, 95% confidence interval 1.1-11). The BsmI and TaqI polymorphisms did not show any significant association with AH. Serum osteocalcin levels were significantly higher in the group with the AA genotype compared with those with the Aa or aa genotype ( P=0.02, P=0.05, respectively). The results indicate that the ApaI AA genotype of the VDR gene is not only associated with AH but is also related to differences in serum osteocalcin.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15141345     DOI: 10.1007/s00467-004-1490-4

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  26 in total

1.  The role of 1 alpha, 25-dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria.

Authors:  R A Kaplan; M R Haussler; L J Deftos; H Bone; C Y Pak
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

2.  Evidence for disordered control of 1,25-dihydroxyvitamin D production in absorptive hypercalciuria.

Authors:  A E Broadus; K L Insogna; R Lang; A F Ellison; B E Dreyer
Journal:  N Engl J Med       Date:  1984-07-12       Impact factor: 91.245

3.  Increased sensitivity to 1,25(OH)2D3 in bone from genetic hypercalciuric rats.

Authors:  N S Krieger; V M Stathopoulos; D A Bushinsky
Journal:  Am J Physiol       Date:  1996-07

4.  Contribution of trans-acting factor alleles to normal physiological variability: vitamin D receptor gene polymorphism and circulating osteocalcin.

Authors:  N A Morrison; R Yeoman; P J Kelly; J A Eisman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

5.  Evidence for normal vitamin D receptor messenger ribonucleic acid and genotype in absorptive hypercalciuria.

Authors:  J E Zerwekh; M R Hughes; B Y Reed; N A Breslau; H J Heller; M Lemke; I Nasonkin; C Y Pak
Journal:  J Clin Endocrinol Metab       Date:  1995-10       Impact factor: 5.958

6.  Prediction of bone density from vitamin D receptor alleles.

Authors:  N A Morrison; J C Qi; A Tokita; P J Kelly; L Crofts; T V Nguyen; P N Sambrook; J A Eisman
Journal:  Nature       Date:  1994-01-20       Impact factor: 49.962

7.  Selective jejunal hyperabsorption of calcium in absorptive hypercalciuria.

Authors:  P G Brannan; S Morawski; C Y Pak; J S Fordtran
Journal:  Am J Med       Date:  1979-03       Impact factor: 4.965

8.  Polymorphisms in the vitamin D receptor gene and the risk of calcium nephrolithiasis in children.

Authors:  Ozan Ozkaya; Oğuz Söylemezoğlu; Müge Misirlioğlu; Sevim Gönen; Necla Buyan; Enver Hasanoğlu
Journal:  Eur Urol       Date:  2003-07       Impact factor: 20.096

9.  Association of vitamin D receptor gene polymorphism with urolithiasis.

Authors:  Saori Nishijima; Kimio Sugaya; Ayako Naito; Makoto Morozumi; Tadashi Hatano; Yoshihide Ogawa
Journal:  J Urol       Date:  2002-05       Impact factor: 7.450

10.  Association of prostate cancer with vitamin D receptor gene polymorphism.

Authors:  J A Taylor; A Hirvonen; M Watson; G Pittman; J L Mohler; D A Bell
Journal:  Cancer Res       Date:  1996-09-15       Impact factor: 12.701

View more
  5 in total

1.  Update on the genetics of nephrolithiasis.

Authors:  Giuseppe Vezzoli; Teresa Arcidiacono; Vera Paloschi; Annalisa Terranegra; Rita Biasion; Laura Soldati
Journal:  Clin Cases Miner Bone Metab       Date:  2008-05

2.  Metabolic abnormalities and polymorphisms of the vitamin D receptor (VDR) and ZNF365 genes in children with urolithiasis.

Authors:  Martha Medina-Escobedo; Lizbeth González-Herrera; Salha Villanueva-Jorge; Gloria Martín-Soberanis
Journal:  Urolithiasis       Date:  2014-07-25       Impact factor: 3.436

3.  Hypocitraturia: a risk factor for reduced bone mineral density in idiopathic hypercalciuria?

Authors:  Maria-Goretti Moreira Guimarães Penido; Eleonora Moreira Lima; Marcelo Ferraz Oliveira Souto; Viviane Santuari Parizotto Marino; Ana-Luiza Fialho Tupinambá; Anderson França
Journal:  Pediatr Nephrol       Date:  2005-10-27       Impact factor: 3.714

4.  Plasma and urinary levels of cytokines in patients with idiopathic hypercalciuria.

Authors:  Augusto C S Santos; Eleonora M Lima; Maria Goretti M G Penido; Katia D Silveira; Mauro M Teixeira; Eduardo A Oliveira; Ana Cristina Simões E Silva
Journal:  Pediatr Nephrol       Date:  2012-01-07       Impact factor: 3.714

Review 5.  Genetic basis of renal cellular dysfunction and the formation of kidney stones.

Authors:  Saeed R Khan; Benjamin K Canales
Journal:  Urol Res       Date:  2009-06-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.